Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Weldon

Showing results (91-100 of 156) with videos related to

Pageof 16
Sort By:
Vaccine|March 8, 2018
Seroprevalence of anti-polio antibodies in children from polio high risk area of Afghanistan: A cross sectional survey 2017Imtiaz Hussain, Ondrej Mach, Nasir A Hamid, et al.
The Lancet. Infectious Diseases|June 22, 2015
Monovalent type-1 oral poliovirus vaccine given at short intervals in Pakistan: a randomised controlled, four-arm, open-label, non-inferiority trialFatima Mir, Farheen Quadri, Ondrej Mach, et al.
Msystems|March 12, 2020
Metabolome-Informed Microbiome Analysis Refines Metadata Classifications and Reveals Unexpected Medication Transfer in Captive CheetahsJulia M Gauglitz, James T Morton, Anupriya Tripathi, et al.
The Journal of Infectious Diseases|July 5, 2020
A Randomized Phase 4 Study of Immunogenicity and Safety After Monovalent Oral Type 2 Sabin Poliovirus Vaccine Challenge in Children Vaccinated with Inactivated Poliovirus Vaccine in LithuaniaAnanda S Bandyopadhyay, Chris Gast, Elizabeth B Brickley, et al.
Vaccine|October 18, 2015
Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trialAbhijeet Anand, K Zaman, Concepción F Estívariz, et al.
Biologicals : Journal of the International Association of Biological Standardization|March 18, 2018
Assessing the potency and immunogenicity of inactivated poliovirus vaccine after exposure to freezing temperaturesJessica A White, Marcus Estrada, William C Weldon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2018
Impact of Maternal Antibody on the Immunogenicity of Inactivated Polio Vaccine in Infants Immunized With Bivalent Oral Polio Vaccine: Implications for the Polio Eradication EndgameJames T Gaensbauer, Chris Gast, Ananda S Bandyopadhyay, et al.
The Cochrane Database of Systematic Reviews|April 14, 2022
Treatment of periodontitis for glycaemic control in people with diabetes mellitusTerry C Simpson, Janet E Clarkson, Helen V Worthington, et al.
Vaccine|August 15, 2024
Assessing the mucosal intestinal and systemic humoral immunity of sequential schedules of inactivated poliovirus vaccine and bivalent oral poliovirus vaccine for essential immunization in Bangladesh: An open-label, randomized controlled trialCynthia J Snider, Khalequ Zaman, Concepcion F Estivariz, et al.
The Journal of Infectious Diseases|October 16, 2014
Factors contributing to outbreaks of wild poliovirus type 1 infection involving persons aged ≥15 years in the Democratic Republic of the Congo, 2010-2011, informed by a pre-outbreak poliovirus immunity assessmentMary M Alleman, Kathleen A Wannemuehler, William C Weldon, et al.
Pageof 16

Showing results (91-100 of 156) with videos related to

Sort By:
Pageof 16
Vaccine|March 8, 2018
Seroprevalence of anti-polio antibodies in children from polio high risk area of Afghanistan: A cross sectional survey 2017Imtiaz Hussain, Ondrej Mach, Nasir A Hamid, et al.
The Lancet. Infectious Diseases|June 22, 2015
Monovalent type-1 oral poliovirus vaccine given at short intervals in Pakistan: a randomised controlled, four-arm, open-label, non-inferiority trialFatima Mir, Farheen Quadri, Ondrej Mach, et al.
Msystems|March 12, 2020
Metabolome-Informed Microbiome Analysis Refines Metadata Classifications and Reveals Unexpected Medication Transfer in Captive CheetahsJulia M Gauglitz, James T Morton, Anupriya Tripathi, et al.
The Journal of Infectious Diseases|July 5, 2020
A Randomized Phase 4 Study of Immunogenicity and Safety After Monovalent Oral Type 2 Sabin Poliovirus Vaccine Challenge in Children Vaccinated with Inactivated Poliovirus Vaccine in LithuaniaAnanda S Bandyopadhyay, Chris Gast, Elizabeth B Brickley, et al.
Vaccine|October 18, 2015
Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trialAbhijeet Anand, K Zaman, Concepción F Estívariz, et al.
Biologicals : Journal of the International Association of Biological Standardization|March 18, 2018
Assessing the potency and immunogenicity of inactivated poliovirus vaccine after exposure to freezing temperaturesJessica A White, Marcus Estrada, William C Weldon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2018
Impact of Maternal Antibody on the Immunogenicity of Inactivated Polio Vaccine in Infants Immunized With Bivalent Oral Polio Vaccine: Implications for the Polio Eradication EndgameJames T Gaensbauer, Chris Gast, Ananda S Bandyopadhyay, et al.
The Cochrane Database of Systematic Reviews|April 14, 2022
Treatment of periodontitis for glycaemic control in people with diabetes mellitusTerry C Simpson, Janet E Clarkson, Helen V Worthington, et al.
Vaccine|August 15, 2024
Assessing the mucosal intestinal and systemic humoral immunity of sequential schedules of inactivated poliovirus vaccine and bivalent oral poliovirus vaccine for essential immunization in Bangladesh: An open-label, randomized controlled trialCynthia J Snider, Khalequ Zaman, Concepcion F Estivariz, et al.
The Journal of Infectious Diseases|October 16, 2014
Factors contributing to outbreaks of wild poliovirus type 1 infection involving persons aged ≥15 years in the Democratic Republic of the Congo, 2010-2011, informed by a pre-outbreak poliovirus immunity assessmentMary M Alleman, Kathleen A Wannemuehler, William C Weldon, et al.
Pageof 16